These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 11057021)
1. [Molecular basis of achondroplasia, hypochondroplasia, and thanatophoric dysplasia]. Moskalewski S; Hyc A; Osiecka-Iwan A; Strzelczyk P Chir Narzadow Ruchu Ortop Pol; 2000; 65(3):327-33. PubMed ID: 11057021 [TBL] [Abstract][Full Text] [Related]
2. Mutations in the fibroblast growth factor receptor 3 (FGFR3) cause achondroplasia, hypochondroplasia, and thanatophoric dysplasia: Taiwanese data. Tsai FJ; Tsai CH; Chang JG; Wu JY Am J Med Genet; 1999 Sep; 86(3):300-1. PubMed ID: 10482885 [No Abstract] [Full Text] [Related]
3. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Naski MC; Wang Q; Xu J; Ornitz DM Nat Genet; 1996 Jun; 13(2):233-7. PubMed ID: 8640234 [TBL] [Abstract][Full Text] [Related]
4. Review of the recently defined molecular mechanisms underlying thanatophoric dysplasia and their potential therapeutic implications for achondroplasia. Martínez-Frías ML; de Frutos CA; Bermejo E; Nieto MA; Am J Med Genet A; 2010 Jan; 152A(1):245-55. PubMed ID: 20034074 [TBL] [Abstract][Full Text] [Related]
5. [From gene to disease; achondroplasia and other skeletal dysplasias due to an activating mutation in the fibroblast growth factor]. van Ravenswaaij-Arts CM; Losekoot M Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1056-9. PubMed ID: 11414167 [TBL] [Abstract][Full Text] [Related]
6. [Mutations of FGFR3 gene cause 3 types of nanisms with variably severity: achondroplasia, thanatophoric nanism and hypochondroplasia]. Rousseau F; Bonaventure J; Le Merrer M; Maroteaux P; Munnich A Ann Endocrinol (Paris); 1996; 57(3):153. PubMed ID: 8949408 [No Abstract] [Full Text] [Related]
7. Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism. Bonaventure J; Rousseau F; Legeai-Mallet L; Le Merrer M; Munnich A; Maroteaux P Am J Med Genet; 1996 May; 63(1):148-54. PubMed ID: 8723101 [TBL] [Abstract][Full Text] [Related]
8. HDAC6 deficiency or inhibition blocks FGFR3 accumulation and improves bone growth in a model of achondroplasia. Ota S; Zhou ZQ; Romero MP; Yang G; Hurlin PJ Hum Mol Genet; 2016 Oct; 25(19):4227-4243. PubMed ID: 27506979 [TBL] [Abstract][Full Text] [Related]
9. Mutant activated FGFR3 impairs endochondral bone growth by preventing SOX9 downregulation in differentiating chondrocytes. Zhou ZQ; Ota S; Deng C; Akiyama H; Hurlin PJ Hum Mol Genet; 2015 Mar; 24(6):1764-73. PubMed ID: 25432534 [TBL] [Abstract][Full Text] [Related]
10. Occurrence of thanatophoric dysplasia type I (R248C) and hypochondroplasia (N540K) mutations in two patients with achondroplasia phenotype. Camera G; Baldi M; Strisciuglio G; Concolino D; Mastroiacovo P; Baffico M Am J Med Genet; 2001 Dec; 104(4):277-81. PubMed ID: 11754059 [TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor receptor 3 and the human chondrodysplasias. Horton WA Curr Opin Pediatr; 1997 Aug; 9(4):437-42. PubMed ID: 9300204 [TBL] [Abstract][Full Text] [Related]
13. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Su WC; Kitagawa M; Xue N; Xie B; Garofalo S; Cho J; Deng C; Horton WA; Fu XY Nature; 1997 Mar; 386(6622):288-92. PubMed ID: 9069288 [TBL] [Abstract][Full Text] [Related]
14. Disruption of a Sox9-β-catenin circuit by mutant Fgfr3 in thanatophoric dysplasia type II. Shung CY; Ota S; Zhou ZQ; Keene DR; Hurlin PJ Hum Mol Genet; 2012 Nov; 21(21):4628-44. PubMed ID: 22843502 [TBL] [Abstract][Full Text] [Related]
15. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Bellus GA; McIntosh I; Smith EA; Aylsworth AS; Kaitila I; Horton WA; Greenhaw GA; Hecht JT; Francomano CA Nat Genet; 1995 Jul; 10(3):357-9. PubMed ID: 7670477 [TBL] [Abstract][Full Text] [Related]
16. Bone dysplasia series. Achondroplasia, hypochondroplasia and thanatophoric dysplasia: review and update. Lemyre E; Azouz EM; Teebi AS; Glanc P; Chen MF Can Assoc Radiol J; 1999 Jun; 50(3):185-97. PubMed ID: 10405653 [TBL] [Abstract][Full Text] [Related]
17. A common FGFR3 gene mutation is present in achondroplasia but not in hypochondroplasia. Stoilov I; Kilpatrick MW; Tsipouras P Am J Med Genet; 1995 Jan; 55(1):127-33. PubMed ID: 7702086 [TBL] [Abstract][Full Text] [Related]
18. Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice. Iwata T; Li CL; Deng CX; Francomano CA Hum Mol Genet; 2001 Jun; 10(12):1255-64. PubMed ID: 11406607 [TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone receptor type 1/Indian hedgehog expression is preserved in the growth plate of human fetuses affected with fibroblast growth factor receptor type 3 activating mutations. Cormier S; Delezoide AL; Benoist-Lasselin C; Legeai-Mallet L; Bonaventure J; Silve C Am J Pathol; 2002 Oct; 161(4):1325-35. PubMed ID: 12368206 [TBL] [Abstract][Full Text] [Related]
20. Common mutations in the gene encoding fibroblast growth factor receptor 3 account for achondroplasia, hypochondroplasia and thanatophoric dysplasia. Bonaventure J; Rousseau F; Legeai-Mallet L; Le Merrer M; Munnich A; Maroteaux P Acta Paediatr Suppl; 1996 Oct; 417():33-8. PubMed ID: 9055906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]